Relmada Therapeutics Price Chart
Relmada Therapeutics Volume Chart
Relmada Therapeutics Market Segments
Premarket
*No Trades in Segment
After Hours Yesterday
+0.26(+3.59%)
| Open | $7.24 |
|---|---|
| Close | $7.50 |
| Low | $7.24 |
| Low Change | 0.00 (0.00%) |
| High | $7.50 |
| High Change | +0.26 (+3.59%) |
| Range | $0.26 |
| Volume | 15.49K |
| Dollar Volume | $116.18K |
Regular Trading Hours Yesterday
+0.24(+3.36%)
| Open | $7.00 |
|---|---|
| Close | $7.24 |
| Low | $6.82 |
| Low Change | -0.18 (-2.60%) |
| High | $7.26 |
| High Change | +0.26 (+3.71%) |
| Range | $0.44 |
| Volume | 996.949K |
| Dollar Volume | $7.21M |
Premarket Yesterday
*No Trades in Segment
Relmada Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $7.16 |
|---|---|
| 10 Day Moving Average (SMA10) | $7.20 |
| 20 Day Moving Average (SMA20) | $7.16 |
| 50 Day Moving Average (SMA50) | $6.11 |
| 100 Day Moving Average (SMA100) | $5.11 |
| 200 Day Moving Average (SMA200) | $3.46 |
Relmada Therapeutics Statistics
| Average Volume (30 Days) | 1.4M |
|---|---|
| P/E Ratio (Current) | -12.78 |
| EPS (Current) | -$0.55 |
| Dividend Yield | 0.00% |
| Free Cash Flow | — |
| Cash Ratio | 0.54 |
| Current Ratio | 14.62 |
| Quick Ratio | 14.62 |
| Debt to Equity | 0.00 |
| Enterprise Value | $733.87M |
| EV to EBITDA | -12.42 |
| EV to Sales | — |
| Price to Book | 8.52 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.61% |
| Return on Equity | -0.66% |
Relmada Therapeutics Stock Splits
There have been 2 stock splits for Relmada Therapeutics (RLMD). The last reverse stock split occured on September 30, 2019 and reduced the outstanding shares at a ratio of 4:1.
| Date | Type | Ratio |
|---|---|---|
| Sep 30, 2019 | Reverse | 4:1 |
| Aug 12, 2015 | Reverse | 5:1 |
Relmada Therapeutics Dividends
There have been no dividends for Relmada Therapeutics (RLMD).